Hua Medicine (Shanghai) Ltd.

HKEX:2552.HK

1.67 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016
Revenue 76.6117.59908.66422.2579.12910.5150.595
Cost of Revenue 39.2369.91000000
Gross Profit 37.3747.68908.66422.2579.12910.5150.595
Gross Profit Ratio 0.4880.437011111
Reseach & Development Expenses 171.537129.528186.835220.962321.904269.065125.33775.272
General & Administrative Expenses 124.148129.931134.835140.084146.584139.31631.08619.482
Selling & Marketing Expenses 79.75515.348000000
SG&A 203.903145.279134.835140.084146.584139.31631.08619.482
Other Expenses 0-26.445-6.49-8.664-22.257-3,266.169-126.483-274.417
Operating Expenses 37.374248.362315.18352.382446.231399.252145.90894.159
Operating Income -289.092-199.581-320.517-389.839-422.639-399.252-145.908-94.159
Operating Income Ratio -3.774-11.340-44.995-18.989-43.734-13.876-158.25
Total Other Income Expenses Net 77.858-3.926-4.064-40.75220.961-3,243.664-134.78-268.249
Income Before Tax -211.234-203.507-325.734-393.134-425.27-3,603.998-280.688-362.408
Income Before Tax Ratio -2.757-11.5640-45.376-19.107-394.786-26.694-609.089
Income Tax Expense 00.2595.2173.2952.631-3,201.212-141.581-265.738
Net Income -211.234-203.766-330.951-396.429-427.901-3,602.726-272.714-361.328
Net Income Ratio -2.757-11.5780-45.756-19.225-394.646-25.936-607.274
EPS -0.22-0.21-0.35-0.42-0.45-10.07-0.26-0.34
EPS Diluted -0.22-0.21-0.35-0.42-0.45-10.07-0.26-0.34
EBITDA -167.089-168.063-309.686-347.433-442.87-358.8-145.271-93.398
EBITDA Ratio -2.181-9.5350-42.866-18.52-394.257-26.522-602.447